CVS Health Corporation (NYSE:CVS) traded with a cut of -0.32 points or -0.33% at $96.67 per share. As per the last available information, the stock aggregated $152.43 million in upticks and $106.07 million in downticks, keeping the net money flow capped at $46.36 million. The up/down ratio was found to be 1.44. For the week, the shares have seen a change of 0.45% in the share price.A block trade of $71.01 million in upticks and $16.37 million in downticks also took place during the day. The up/down ratio for the block stood at 4.34. The net money flow for this transaction was $54.64 million.
Currently the company Insiders own 0.58% of CVS Health Corporation shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by -10.31% . Institutional Investors own 85.28% of CVS Health Corporation shares. During last six month period, the net percent change held by insiders has seen a change of -20.69%. On the companys insider trading activities, The director officer (President and CEO), of Cvs Health Corp, Merlo Larry J had unloaded 38,247 shares at $105 per share in a transaction on May 5, 2016. The total value of transaction was $4,015,935. The Insider information was revealed by the Securities and Exchange Commission in a Form 4 filing.
CVS Health Corporation (NYSE:CVS) stock ended Monday session in the red zone in a volatile trading. The stock closed down 0.89 points or 0.92% at $95.78 with 6,098,739 shares getting traded. Post opening the session at $96.5, the shares hit an intraday low of $95.6 and an intraday high of $96.83 and the price was in this range throughout the day. The company has a market cap of $102,870 million and the number of outstanding shares have been calculated to be 1,074,022,090 shares. The 52-week high of CVS Health Corporation (NYSE:CVS) is $113.65 and the 52-week low is $81.37.
Many analysts have stated their opinion on the company shares. Major Brokerage house, Jefferies maintains its ratings on CVS Health Corporation (NYSE:CVS). In the latest research report, Jefferies raises the target price from $110 per share to $122 per share. According to the latest information available, the shares are now rated Buy by the analysts at the agency. The rating by the firm was issued on May 12, 2016.
CVS Health Corporation, together with its subsidiaries, is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services, Novologix and Navarro Health Services names. The Retail Pharmacy segment sells prescription drugs and an assortment of general merchandise, including over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, photo finishing, seasonal merchandise and greeting cards through the Companys retail stores, online retail pharmacy Websites and retail healthcare clinics. The Corporate segment provides management and administrative services to support the overall operations of the Company. The Company, through its wholly owned subsidiary, Omnicare, Inc., provides pharmacy services to long term care facilities.